Scott Braunstein Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Braunstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Braunstein. Scott Braunstein is Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Chief Executive Officer in MARINUS PHARMACEUTICALS INC ($MRNS) and Executive Chairman in MARINUS PHARMACEUTICALS INC ($MRNS) and Director in ArTara Therapeutics, Inc. ($PRTO) and Chief Operating Officer in Pacira Pharmaceuticals, Inc. ($PCRX) and SVP, Strategy & Corp. Dev. in Pacira Pharmaceuticals, Inc. ($PCRX) and Director in TREVENA INC ($TRVN) and in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Esperion Therapeutics, Inc. ($ESPR).
Latest Insider Trading Transactions of Scott Braunstein
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CNST, ESPR, MRNS, PCRX, TARA, TRVN, ZIOP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Chief Executive Off ... | Option Exercise | A | 12.60 | 290,000 | 3,654,000 | 290,000 | |
| Jun 11 2020 | TARA | Protara Therapeuti ... | Braunstein Scott | Director | Option Exercise | A | 35.00 | 9,000 | 315,000 | 9,000 | |
| Jun 08 2020 | CNST | CONSTELLATION PHAR ... | Braunstein Scott | Option Exercise | A | 37.52 | 13,171 | 494,176 | 13,171 | ||
| May 15 2020 | TRVN | TREVENA INC | Braunstein Scott | Director | Option Exercise | A | 1.05 | 64,103 | 67,308 | 64,103 | |
| Jan 13 2020 | PRTO | ArTara Therapeutic ... | Braunstein Scott | Director | Option Exercise | A | 9.18 | 15,737 | 144,466 | 15,737 | |
| Jan 13 2020 | PRTO | ArTara Therapeutic ... | Braunstein Scott | Director | Option Exercise | A | 9.18 | 6,676 | 61,286 | 6,676 | |
| Jan 13 2020 | PRTO | ArTara Therapeutic ... | Braunstein Scott | Director | Option Exercise | A | 9.18 | 9,537 | 87,550 | 9,537 | |
| Jan 13 2020 | PRTO | ArTara Therapeutic ... | Braunstein Scott | Director | Option Exercise | A | 9.18 | 2,861 | 26,264 | 2,861 | |
| Jan 13 2020 | PRTO | ArTara Therapeutic ... | Braunstein Scott | Director | Option Exercise | A | 9.18 | 9,537 | 87,550 | 9,537 | |
| Jan 13 2020 | PRTO | ArTara Therapeutic ... | Braunstein Scott | Director | Grant | A | 0.00 | 26,500 | 0 | 26,500 | 0 to 26.5 K |
| Jan 10 2020 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Chief Executive Off ... | Option Exercise | A | 2.07 | 1,800,000 | 3,726,000 | 1,800,000 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Braunstein Scott | Director | Grant | A | 0.00 | 31,780 | 0 | 31,780 | 0 to 31.8 K |
| Dec 13 2019 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Chief Executive Off ... | Buy | P | 1.25 | 100,000 | 125,000 | 100,000 | 0 to 100 K |
| Aug 08 2019 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Executive Chairman | Option Exercise | A | 1.07 | 1,000,000 | 1,070,000 | 1,000,000 | |
| May 31 2019 | ESPR | Esperion Therapeut ... | Braunstein Scott | Director | Grant | A | 0.00 | 4,967 | 0 | 5,019 | 52 to 5 K (+9,551.92 %) |
| May 31 2019 | ESPR | Esperion Therapeut ... | Braunstein Scott | Director | Grant | A | 0.00 | 4,967 | 0 | 5,019 | 52 to 5 K (+9,551.92 %) |
| May 16 2019 | TRVN | TREVENA INC | Braunstein Scott | Director | Option Exercise | A | 1.34 | 30,000 | 40,200 | 30,000 | |
| Feb 28 2019 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Executive Chairman | Option Exercise | A | 3.96 | 240,000 | 950,400 | 240,000 | |
| Feb 20 2019 | CNST | CONSTELLATION PHAR ... | Braunstein Scott | Director | Option Exercise | A | 10.81 | 26,342 | 284,757 | 26,342 | |
| Jan 02 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Braunstein Scott | Director | Option Exercise | A | 1.87 | 126,700 | 236,929 | 126,700 | |
| Oct 01 2018 | TRVN | TREVENA INC | Braunstein Scott | Director | Option Exercise | A | 2.25 | 60,000 | 135,000 | 60,000 | |
| Sep 20 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | Braunstein Scott | Director | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
| May 25 2018 | ESPR | Esperion Therapeut ... | Braunstein Scott | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
| Jan 05 2018 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | Chief Operating Off ... | Option Exercise | A | 46.35 | 60,000 | 2,781,000 | 60,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 44.20 | 22,000 | 972,400 | 22,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 44.10 | 10,000 | 441,000 | 10,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 11,000 | 0 | 20,982 | 10 K to 21 K (+110.20 %) |
| Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Sell | S | 43.32 | 768 | 33,271 | 9,982 | 10.8 K to 10 K (-7.14 %) |
| Apr 19 2017 | ESPR | Esperion Therapeut ... | Braunstein Scott | Director | Option Exercise | A | 38.96 | 14,000 | 545,440 | 14,000 | |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 32.35 | 20,000 | 647,000 | 20,000 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 8,750 | 0 | 10,750 | 2 K to 10.8 K (+437.50 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 8,750 | 0 | 10,750 | 2 K to 10.8 K (+437.50 %) |
| Jun 10 2016 | ESPR | Esperion Therapeut ... | Braunstein Scott | Director | Option Exercise | A | 17.75 | 8,000 | 142,000 | 8,000 | |
| Feb 01 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Buy | P | 58.92 | 2,000 | 117,840 | 2,000 | 0 to 2 K |
| Aug 21 2015 | ESPR | Esperion Therapeut ... | Braunstein Scott | Director | Option Exercise | A | 57.54 | 20,000 | 1,150,800 | 20,000 | |
| Jul 15 2015 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 67.11 | 75,000 | 5,033,250 | 75,000 |
Page: 1